Dr. Nicholas Gonzalez

Developer of an enzyme-based alternative cancer therapy (the Gonzalez Protocol) who died suddenly on July 21, 2015, at age 67, of an apparent cardiac event at his Manhattan home. Preliminary autopsy results did not support the initial belief of a heart attack, and the final cause of death has never been publicly clarified. His death occurred during the summer 2015 wave of holistic doctor deaths.

Field	Details
Full Name	Nicholas James Gonzalez
Born	December 28, 1947, Flushing, Queens, New York
Died	July 21, 2015 (age 67), Manhattan, New York City
Cause of Death	Apparent cardiac event; preliminary autopsy did not confirm heart attack
Official Ruling	Natural causes (initially reported as heart attack; autopsy inconclusive)
Role	Physician / Alternative Cancer Researcher
Education	B.A. English Literature, Brown University (Phi Beta Kappa, magna cum laude); Postgraduate premedical studies, Columbia University; M.D., Cornell University Medical College (1983); Immunology fellowship under Dr. Robert A. Good
Credentials	Licensed physician, New York; private practice in Manhattan since 1987
Platform	Private practice, published books, medical journals, conference lectures, documentary appearances
Notable Works	One Man Alone (2010); What Went Wrong (2012); Conquering Cancer Vols. 1 & 2; The Trophoblast and the Origins of Cancer; Nutrition and the Autonomic Nervous System
Evidence Rating	SUSPICIOUS

Assessment: Scope and Relevance

Dr. Nicholas Gonzalez's work falls under medical research suppression rather than UAP physics. His enzyme-based cancer protocol challenged the conventional oncology establishment and the pharmaceutical cancer treatment industry. He is included in this project because his death is one of the most prominent cases in the 2015 holistic doctor death wave and because the pattern of suppressing alternative scientific research — whether in medicine, energy, or physics — reflects the same institutional dynamics documented throughout this investigation. The suppression of unconventional cancer treatments parallels the suppression of unconventional energy and physics research: in both cases, researchers who challenge entrenched paradigms allegedly face institutional retaliation, career destruction, and in some cases, death.

Biography

Early Life and Education

Nicholas James Gonzalez was born on December 28, 1947, in Flushing, Queens, New York. He was of partial Mexican and Italian descent. His grandfather, Guillermo Gonzalez, was a renowned Mexican cellist who performed with the Metropolitan Opera in New York City. Gonzalez was raised in Queens and attended New York City public schools.

He attended Brown University, where he graduated Phi Beta Kappa and magna cum laude with a degree in English literature. After Brown, he worked as a journalist for Time Inc. from 1970 to 1977, covering health-related topics. His journalism credits included a July 1972 cover story for New York Magazine, a 1976 cover story for Family Health Magazine, and articles for Prevention Magazine.

Gonzalez then completed postgraduate premedical studies at Columbia University before entering Cornell University Medical College, from which he received his M.D. in 1983.

The Kelley Investigation

The pivotal moment in Gonzalez's career came during his second year at Cornell in 1981, when he was introduced to Dr. William Donald Kelley, a Texas orthodontist who had been treating cancer patients with an enzyme-based nutritional therapy since the 1960s. Kelley's protocol was based on the trophoblastic theory of cancer — the idea that pancreatic proteolytic enzymes are the body's primary defense against cancer, and that supplementing these enzymes could arrest and reverse tumor growth.

Gonzalez's research advisor at Cornell was Dr. Robert A. Good, then president of Memorial Sloan Kettering Cancer Center and widely considered the "father of modern immunology." Good agreed to supervise a formal case review of Kelley's patient records. Over the next several years, Gonzalez reviewed nearly 10,000 of Kelley's patient records and conducted intensive interviews and evaluations of over 500 patients with appropriately diagnosed advanced cancer.

The results, according to Gonzalez, were striking: he documented cases of patients with advanced, poor-prognosis cancers — including pancreatic cancer, metastatic breast cancer, and other aggressive malignancies — who had survived years or decades longer than expected on Kelley's enzyme protocol. This research formed the basis of his 1986 monograph, later published as One Man Alone: An Investigation of Nutrition, Cancer, and William Donald Kelley (2010).

The Gonzalez Protocol

After completing a postdoctoral immunology fellowship under Dr. Good, Gonzalez established his private practice in Manhattan in 1987. He refined Kelley's approach into what became known as the Gonzalez Protocol (or Gonzalez Regimen), which consisted of three core components:

1. Individualized diet — Tailored nutritional plans based on the patient's metabolic type, ranging from largely plant-based to including significant amounts of animal protein, with emphasis on organic, whole foods
2. Pancreatic enzyme supplementation — Large doses of porcine pancreatic enzymes (the central therapeutic agent), along with up to 150 dietary supplement capsules per day including vitamins, minerals, and trace elements
3. Detoxification routines — Including twice-daily coffee enemas, liver flushes, and other procedures intended to help the body eliminate waste products from tumor breakdown

Gonzalez treated patients with a wide range of cancer diagnoses, though he became best known for his work with pancreatic cancer — one of the deadliest malignancies, with a five-year survival rate under 10%.

The NCI Clinical Trial (The Chabot Study)

Background

Gonzalez's most consequential — and most controversial — professional endeavor was a federally funded clinical trial comparing his enzyme protocol to standard chemotherapy for pancreatic cancer. In 1998, after Gonzalez published a pilot study in the peer-reviewed journal Nutrition and Cancer reporting that 11 patients with inoperable pancreatic cancer treated with his protocol survived a median of 17 months (compared to the typical 4-6 months), the National Cancer Institute (NCI) took notice. The NCI and the National Center for Complementary and Alternative Medicine (NCCAM) awarded a $1.4 million grant in 1999 to Columbia University's Rosenthal Center for Alternative Medicine to conduct a randomized phase III clinical trial.

The Trial

The study (NCT00003851) was designed to compare the Gonzalez regimen against gemcitabine-based chemotherapy in patients with stage II-IV inoperable pancreatic adenocarcinoma. The principal investigator was Dr. John Chabot, a surgical oncologist at Columbia University Medical Center. The trial aimed to enroll 72 to 90 patients.

Results

The results, published in the Journal of Clinical Oncology in April 2010, were devastating for Gonzalez:

• Chemotherapy arm: Median survival of 14 months
• Gonzalez regimen arm: Median survival of 4.3 months
• Chemotherapy patients also reported better quality of life

Gonzalez's Objections

Gonzalez vigorously disputed the trial's validity. He argued that the study had been sabotaged from within by investigators hostile to his protocol. His objections included:

• Patient enrollment violations: The Office for Human Research Protections (OHRP) investigated and found that Dr. Chabot had improperly approved 42 out of 62 total patients, including 40 for whom he failed to obtain appropriate written informed consent
• Protocol violations: OHRP found patients enrolled who had significant psychiatric illness (in violation of eligibility criteria), patients enrolled more than 8 weeks after diagnosis (violating protocol requirements), and informed consent documents that failed to list the risk of death from coffee enemas
• Selection bias: Gonzalez alleged that Chabot steered healthier patients toward the chemotherapy arm and sicker patients toward the enzyme arm
• Compliance failures: Gonzalez claimed many patients randomized to his protocol never actually followed it — a critical problem since the regimen required strict adherence to a demanding daily routine of diet, 150+ supplement pills, and twice-daily coffee enemas
• Hostile management: Gonzalez believed the trial was deliberately mismanaged by investigators who wanted his treatment to fail

Gonzalez documented these objections in his 2012 book What Went Wrong: The Truth Behind the Clinical Trial of the Enzyme Treatment of Cancer, which won a Silver Award in the Independent Book Publishers Association's 2013 Benjamin Franklin Awards (Science category).

OHRP Findings

The OHRP investigation substantiated several of Gonzalez's procedural complaints. A determination letter from OHRP to Columbia confirmed that:

• Dr. Chabot admitted to the managerial lapses in patient enrollment
• 40 patients were not appropriately consented
• Eligibility criteria were violated
• Columbia was required to implement a program for training in appropriate research methodology

However, these procedural findings did not change the published results, and the oncology establishment accepted the trial as evidence that the Gonzalez Protocol was inferior to chemotherapy for pancreatic cancer.

Legal Issues

Gonzalez faced two significant malpractice cases:

• 1997: A New York court found Gonzalez negligent in the treatment of a patient with uterine cancer. According to court records, Gonzalez had discouraged the patient from following through on her cancer specialist's advice, instead recommending dietary supplements and coffee enemas. After the cancer spread to her spine, the patient discontinued Gonzalez's treatment and received chemotherapy and radiation. Gonzalez was ordered to pay $2.5 million in damages.

• 2000: Gonzalez was found partly liable (49%) in the death of a patient with Hodgkin's lymphoma and ordered to pay $282,000 in damages. The case involved his use of an unproven cancer screening method instead of standard cancer testing.

Publications

Dr. Gonzalez was a prolific author. His published works include:

• One Man Alone: An Investigation of Nutrition, Cancer, and William Donald Kelley (2010, originally completed 1986) — The foundational monograph documenting 50 case histories from Kelley's practice
• What Went Wrong: The Truth Behind the Clinical Trial of the Enzyme Treatment of Cancer (2012) — His account of the NCI clinical trial's alleged sabotage; Silver Award winner, IBPA 2013 Benjamin Franklin Awards (Science)
• The Trophoblast and the Origins of Cancer — On the theoretical basis for enzyme cancer therapy
• Conquering Cancer: Volume One — 50 Pancreatic and Breast Cancer Patients on the Gonzalez Nutritional Protocol
• Conquering Cancer: Volume Two — 62 Patients on the Gonzalez Protocol
• Nutrition and the Autonomic Nervous System — On the metabolic typing framework underlying individualized diet protocols
• Proof of Concept — Additional case documentation
• Pilot study: "Evaluation of Pancreatic Proteolytic Enzyme Treatment of Adenocarcinoma of the Pancreas, With Nutrition and Detoxification Support" — Nutrition and Cancer, 1999

Circumstances of Death

The Event

On July 21, 2015, Dr. Nicholas Gonzalez died at his home in Manhattan, New York City. He was 67 years old. He was initially reported to have died of a heart attack. He passed away alone, and his body was discovered some time after his death.

Autopsy Results

The initial assumption of a heart attack was contradicted by the preliminary autopsy. According to a statement posted on the Gonzalez Foundation website, preliminary autopsy results "do not support the initial belief that he might have suffered a heart attack." Further tests were reported to be underway to determine the cause of death. However, no definitive final cause of death has been publicly disclosed. The inconclusive nature of the autopsy findings has fueled speculation among his supporters.

Wife's Statements

Dr. Gonzalez's wife, Mary Beth Gonzalez (nee Pryor), stated that her husband had been in excellent health at the time of his death and that his passing was completely unexpected. After his death, Mary Beth founded The Nicholas Gonzalez Foundation to preserve his work and make the Gonzalez Protocol accessible to patients and researchers. She has continued to publish his posthumous works and maintain his legacy through the foundation, which operates at thegonzalezprotocol.com.

Gonzalez's Own Statements About Threats

In several interviews before his death — including what was reportedly his final interview — Gonzalez stated that he believed pharmaceutical industry interests wanted him silenced. He reportedly said he thought "big pharma wanted him to get hit by a bus" and that he "might die suddenly." These statements, made prior to his death, are cited by conspiracy theorists as evidence of foreknowledge, though they could equally reflect the general anxiety of someone who spent decades in conflict with powerful institutional interests.

The 2015 Holistic Doctor Death Wave

Gonzalez's death occurred during a cluster of deaths among alternative health practitioners in the summer of 2015. The sequence, as documented by Erin Elizabeth of Health Nut News, included:

Date	Doctor	Circumstances
June 19, 2015	Dr. Jeffrey Bradstreet	Found in river with gunshot to chest, 3 days after FDA raid; ruled suicide
June 21, 2015	Dr. Bruce Hedendal	Chiropractor found dead in car, Boca Raton, FL; age 67
June 21, 2015	Dr. Baron Holt	Florida chiropractor found dead same day as Hedendal
July 2015	Dr. Lisa Riley	Osteopath found with gunshot wound to head; ruled suicide
July 21, 2015	Dr. Nicholas Gonzalez	Apparent cardiac event; autopsy inconclusive
September 15, 2015	Dr. Mitchell Gaynor	Integrative oncologist found dead near home; ruled suicide

The clustering of these deaths within a 90-day period generated widespread attention in alternative health communities. See Holistic Doctor Deaths (2015-Present) for the full documented pattern.

Suspicious Indicators

Factors cited by those who believe Gonzalez's death was not natural:

• No prior heart disease: His wife and colleagues stated he was in excellent health with no known cardiac conditions
• Inconclusive autopsy: Preliminary results did not support the heart attack hypothesis, and no definitive cause of death was publicly announced
• Timing: His death occurred in the middle of the 2015 holistic doctor death cluster
• Motive: Gonzalez had spent nearly 30 years challenging the cancer treatment industry, which generates over $200 billion annually
• His own statements: He had publicly stated he expected pharmaceutical interests might want him dead
• Ongoing work: At the time of his death, Gonzalez was still actively treating patients and publishing books documenting his case histories
• Pattern: His death fits a broader alleged pattern of alternative health practitioners dying under unusual circumstances

Counterarguments

Natural Death Is the Most Likely Explanation

• Age: Gonzalez was 67, an age at which sudden cardiac events are not uncommon in men, even in those with no prior diagnosed heart disease
• Undiagnosed conditions: Many cardiac conditions — arrhythmias, hypertrophic cardiomyopathy, coronary artery disease — can be asymptomatic until a fatal event. An "inconclusive" autopsy does not mean foul play; it may simply mean the specific cardiac mechanism was not identifiable on gross examination
• No evidence of foul play: No law enforcement agency has indicated any evidence of homicide, poisoning, or suspicious circumstances
• Confirmation bias: The "holistic doctor deaths" narrative emerged after Bradstreet's dramatic death and was retrospectively applied to subsequent deaths of health practitioners, many of whom died of clearly natural or unrelated causes
• Base rates: Thousands of physicians die each year in the United States. Some number of alternative health practitioners dying in any given period is statistically expected

The Clinical Trial Undermined His Credibility

• The NCI trial showed his protocol performed worse than chemotherapy — median survival of 4.3 months vs. 14 months. This is the most significant counterargument to the claim that he was silenced: from the oncology establishment's perspective, the Gonzalez Protocol had already been publicly discredited by a peer-reviewed clinical trial
• Malpractice judgments: Two court cases found Gonzalez negligent in his cancer treatment, resulting in over $2.7 million in damages
• OHRP findings cut both ways: While OHRP found enrollment violations, the procedural failures do not necessarily invalidate the outcome. Many oncologists argue the results were so dramatically one-sided (4.3 vs. 14 months) that enrollment irregularities could not account for the difference
• No institutional threat: By 2015, the Gonzalez Protocol was not considered a serious threat by the oncology establishment — the NCI trial had been published five years earlier, and mainstream medicine had moved on

Fact-Checker Assessment

Snopes and other fact-checking organizations investigated the "holistic doctor deaths" narrative and concluded there was no evidence of a coordinated campaign to kill alternative health practitioners. Individual cases ranged from confirmed suicides to natural causes to genuine unsolved homicides, but no connecting thread of conspiracy was substantiated.

Key Quotes

"I believe that when properly applied, the treatment can produce positive results with virtually any type of cancer, even advanced metastatic disease." — Dr. Nicholas Gonzalez, on the enzyme protocol

"Dr. Gonzalez was in excellent health, so his passing is quite unexpected." — Statement from Gonzalez's office, July 2015

"Preliminary autopsy results... do not support the initial belief that he might have suffered a heart attack." — Nicholas Gonzalez Foundation website, 2015

Legacy

After Gonzalez's death, his wife Mary Beth Gonzalez founded The Nicholas Gonzalez Foundation to preserve and continue his work. The foundation publishes his books, maintains his case records, provides information about the Gonzalez Protocol, and works to make his research accessible to patients and practitioners. Mary Beth has stated: "I'll spend the rest of my life honoring you — because loving you was one of the best things I ever got to do."

Dr. Linda Isaacs, who had been Gonzalez's colleague and collaborator for over two decades, continued treating patients with the enzyme protocol after his death, though she later distanced herself from the foundation over disagreements about how his legacy was being managed.

The Gonzalez Protocol continues to have adherents among alternative medicine practitioners and patients, particularly those with cancers considered untreatable by conventional oncology. Whether the protocol has genuine efficacy beyond placebo remains hotly debated, with proponents pointing to individual case histories and critics pointing to the NCI trial results.

See Also

• Dr. Jeffrey Bradstreet — Anti-vaccine researcher found dead in June 2015; the catalyst case for the holistic doctor deaths narrative
• Holistic Doctor Deaths (2015-Present) — The broader pattern of alternative health practitioner deaths beginning in 2015
• Timothy Cunningham — CDC researcher who disappeared in 2018 under suspicious circumstances

Sources

• Nicholas Gonzalez (physician) — Wikipedia
• The Nicholas Gonzalez Foundation
• Gonzalez Regimen (PDQ) — National Cancer Institute
• Gonzalez Regimen (PDQ) — NCBI Bookshelf
• NIH — Gonzalez Regimen Trial: Response to RFC — ASPE/HHS
• NCI-NIH Funded Clinical Study — Nicholas Gonzalez Foundation
• Dr. Nicholas Gonzalez: In Memoriam — Dr. Ronald Hoffman
• In Memoriam: The Life and Times of Dr. Nicholas Gonzalez — Vitality Magazine
• In Memoriam: Nicholas J. Gonzalez (1947-2015) — ACAM
• Five Holistic Doctors Dead — Snopes
• Mary Beth Gonzalez: Preserving Her Husband's Legacy — Nicholas Gonzalez Foundation
• Nicholas Gonzalez: The latest victim of the pharma assassins? — Respectful Insolence
• The Gonzalez Trial for Pancreatic Cancer: Outcome Revealed — Science-Based Medicine

This information was compiled by Claude AI research.

Status: Deceased (2015)